此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Epidemiology of Clostridioides Difficile Infection (CDI) in Long-term Care Facilities, Assessment of Professional Practices Related to CDI Risk Prevention, and Strategies for Improving Care. (EpiCE)

2026年11月2日 更新者:Assistance Publique Hopitaux De Marseille

Clostridioides difficile infection (CDI) is the leading cause of infectious diarrhea among older adults. The epidemiology of community-acquired CDI, particularly among residents of long-term care facilities, remains poorly understood to this day. While numerous studies on the epidemiology, prevention, diagnosis, and treatment of CDI have been conducted in hospital settings, primary care often lags behind these advances. Limited access to diagnostic tests and treatment options, as well as insufficient resources allocated to preventing cross-transmission, are all factors that hinder the control of ICD in long-term care facilities. This will be the first French study on the epidemiology of ICD among nursing home residents, which can serve as a reference for implementing a multidisciplinary action plan and measuring its impact. This will be carried out as part of a city-hospital collaboration and will facilitate the creation of a healthcare network involving multiple healthcare providers, such as general practitioners working in nursing homes, clinical laboratories, pharmacies, dietitians and nutritionists, and the university hospital.

A better understanding of the epidemiology of ICD among residents in long-term care facilities and an assessment of professional practices related to ICD risk prevention should enable us to better target strategies for improving care while raising awareness among healthcare providers and public health policymakers. We therefore plan to optimize the impact of implementing a multidisciplinary action program aligned with the expectations of frontline practitioners regarding the reduction of the risk of ICD (training, prevention tools, diagnosis and treatment of ICD, appropriate use of antibiotics, nutritional counseling, prescribing probiotics, and establishing a coordinated care pathway for ICD). The implementation of this action program is expected to reduce the incidence rate of ICD, the recurrence rate, and antibiotic use in nursing homes, as well as the number of transfers to the hospital for ICD management.

研究概览

地位

尚未招聘

研究类型

观察性的

注册 (估计的)

2000

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Marseille、法国
        • Assistance Publique Hopitaux de Marseille

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

65年 及以上 (年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

residents of nursing homes

描述

Inclusion Criteria:

  • Men or women aged 65 or older
  • Patients who have received information about the study and have not expressed objection
  • Residents of the nursing home for more than 72 hours during the 12-month enrollment period
  • No objection to the use of clinical and biological data in the event of an ICD.

Exclusion Criteria:

  • A patient who is in the exclusion period of another research protocol at the time the informed consent form is obtained.
  • A person who does not understand French
  • No inclusion criteria.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence Rate of ICD
大体时间:24 MONTHS
  • Probable C. difficile infection: diarrhea (>3 loose stools per 24 hours) within two months of taking an antibiotic or within 72 hours of hospitalization.
  • Confirmed C. difficile infection: diarrhea AND detection of Clostridioides difficile toxins.
24 MONTHS

次要结果测量

结果测量
大体时间
the recurrence rate of C. difficile colitis
大体时间:24 MONTHS
24 MONTHS
Measuring the Use of Critical Antibiotics
大体时间:24 MONTHS
24 MONTHS
Measure the number of hospital transfers for ICD management.
大体时间:24 MONTHS
24 MONTHS
the prevalence of the main risk factors for ICD
大体时间:24MONTHS
24MONTHS

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:cassir nadim、assistance publique hôpitaux de Marseille

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2027年1月1日

初级完成 (估计的)

2027年1月1日

研究完成 (估计的)

2029年2月1日

研究注册日期

首次提交

2026年11月2日

首先提交符合 QC 标准的

2026年11月2日

首次发布 (实际的)

2026年11月5日

研究记录更新

最后更新发布 (实际的)

2026年11月5日

上次提交的符合 QC 标准的更新

2026年11月2日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • RCAPHM26_0189
  • PADS26-262 (其他标识符:APHM)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅